China Money Network
Login
Join

China Biologic Receives Higher Counter Bid From Investor Group Led By Ex-CEO

  • August 21, 2018 — 14:26 CST

This Data Is Locked!

This area is available only to Subscribers.

China Biologic Products Holdings Inc, a leading plasma-based biopharmaceutical company in China, received a $3.9 billion counter offer from an investor consortium led by its... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: